{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:27:50Z","timestamp":1773278870123,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s11926-000-0020-z","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T00:24:53Z","timestamp":1180743893000},"page":"454-458","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of osteoarthritis with acetaminophen: Efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs"],"prefix":"10.1007","volume":"2","author":[{"given":"Mohammed","family":"Shamoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, et al.: Estimates of prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778\u2013799.","journal-title":"Arthritis Rheum"},{"key":"20_CR2","first-page":"1","volume":"23","author":"J Morales-Torres","year":"1996","unstructured":"Morales-Torres J, Reginster JC, Hochberg MC: Rheumatic and musculoskeletal disease and impaired quality of life: a challenge for rheumatologists. J Rheumatol 1996, 23:1\u20133.","journal-title":"J Rheumatol"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0749-0690(18)30100-9","volume":"14","author":"P Creamer","year":"1998","unstructured":"Creamer P, Flores R, Hochberg MC: Management of osteoarthritis in older adults. Clin Geriatr Med 1998, 14:435\u2013454.","journal-title":"Clin Geriatr Med"},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/rheumatology\/36.7.726","volume":"37","author":"P Creamer","year":"1997","unstructured":"Creamer P, Hochberg MC: Why does osteoarthritis of the knee hurt\u2014sometimes? Br J Rheumatol 1997, 37:726\u2013728.","journal-title":"Br J Rheumatol"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/joca.1998.0130","volume":"6","author":"P Creamer","year":"1998","unstructured":"Creamer P, Lethbridge-Cejku M, Hochberg MC: Where does it hurt? Pain localization in osteoarthritis of the knee. Osteoarthritis Cartilage 1998, 6:318\u2013323.","journal-title":"Osteoarthritis Cartilage"},{"key":"20_CR6","first-page":"1785","volume":"26","author":"P Creamer","year":"1999","unstructured":"Creamer P, Lethbridge-Cejku M, Hochberg MC: Determinants of pain severity in knee osteoarthritis: effect of demographic and psychosocial variables using 3 pain measures. J Rheumatol 1999, 26:1785\u20131792.","journal-title":"J Rheumatol"},{"key":"20_CR7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bmj.320.7241.1058","volume":"320","author":"PC Gotzsche","year":"2000","unstructured":"Gotzsche PC: Non-steroidal anti-inflammatory drugs. BMJ 2000, 320:1058\u20131061.","journal-title":"BMJ"},{"key":"20_CR8","first-page":"437","volume":"2","author":"P Dieppe","year":"1999","unstructured":"Dieppe P, Chard J, Faulker A, Lohmander S: Osteoarthritis. Clin Evidence 1999, 2:437\u2013448. Available at: http:\/\/www.evidence.org.","journal-title":"Clin Evidence"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0049-0172(97)80043-1","volume":"26","author":"TE Towheed","year":"1997","unstructured":"Towheed TE, Hochberg MC: A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum 1997, 26:755\u2013770.","journal-title":"Semin Arthritis Rheum"},{"key":"20_CR10","unstructured":"Towheed T,Shea B, Wells G, Hochberg M: Analgesia and nonaspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. In In Cochrane Library, Issue 1. Oxford, Update Software, 2000. Available at: http:\/\/www.cochrane.org."},{"key":"20_CR11","first-page":"391","volume":"27","author":"DL Scott","year":"1993","unstructured":"Scott DL: Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee. J R Coll Phys London 1993, 27:391\u2013396.","journal-title":"J R Coll Phys London"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780381103","volume":"38","author":"MC Hochberg","year":"1995","unstructured":"Hochberg MC, Altman RD, Brandt KD, et al.: Guidelines for the medical management of osteoarthritis: part I: osteoarthritis of the hip. Arthritis Rheum 1995, 38:1535\u20131540.","journal-title":"Arthritis Rheum"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/art.1780381104","volume":"38","author":"MC Hochberg","year":"1995","unstructured":"Hochberg MC, Altman RD, Brandt KD, et al.: Guidelines for the medical management of osteoarthritis. part II: osteoarthritis of the knee. Arthritis Rheum 1995, 38:1541\u20131546.","journal-title":"Arthritis Rheum"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archfami.4.12.1049","volume":"4","author":"MR Griffin","year":"1995","unstructured":"Griffin MR, Brandt KD, Liang M, et al.: Practical management of osteoarthritis: integration of pharmacologic and nonpharmacologic measures. Arch Fam Med 1995, 4:1049\u20131055.","journal-title":"Arch Fam Med"},{"key":"20_CR15","first-page":"631","volume-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"PA Insel","year":"1996","unstructured":"Insel PA: Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In In Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics, edn 9. Edited by Hardman JG, et al. New York: McGraw Hill; 1996:631\u2013633.","edition":"edn 9"},{"key":"20_CR16","first-page":"25","volume":"131","author":"CH Jackson","year":"1984","unstructured":"Jackson CH, MacDonald NC, Cornett JWD: Acetaminophen: a practical pharmacologic overview. Can Med Assoc J 1984, 131:25\u201332.","journal-title":"Can Med Assoc J"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2165\/00003495-198600324-00005","volume":"32","author":"SP Clissold","year":"1986","unstructured":"Clissold SP: Paracetamol and phenacetin. Drugs 1986, 32:46\u201359.","journal-title":"Drugs"},{"key":"20_CR18","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliao F, Vojnovic I, et al.: Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999, 96:7563\u20137568.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/anr.1780320102","volume":"32","author":"SR Abramson","year":"1989","unstructured":"Abramson SR, Weissman G: The mechanisms of action of non-steroidal anti-inflammatory drugs. Arthritis Rheum 1989, 32:1\u20139.","journal-title":"Arthritis Rheum"},{"key":"20_CR20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/240410a0","volume":"240","author":"RJ Flower","year":"1972","unstructured":"Flower RJ, Vane JR: Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol. Nature 1972, 240:410\u2013411.","journal-title":"Nature"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3565(24)36432-8","volume":"280","author":"LA Pini","year":"1991","unstructured":"Pini LA, Vitale G, Ottani A, Sandrini M: Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther 1991, 280:934\u2013940.","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(91)90036-P","volume":"193","author":"A Tjolsen","year":"1991","unstructured":"Tjolsen A, Lund A, Hole K: Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol 1991, 193:193\u2013201.","journal-title":"Eur J Pharmacol"},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00000542-199907000-00032","volume":"91","author":"S Muth-Selbach","year":"1999","unstructured":"Muth-Selbach S, Tegeder I, Brune K, Geisslinger G: Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology 1999, 91:231\u2013239.","journal-title":"Anesthesiology"},{"key":"20_CR24","first-page":"59","volume":"34","author":"P Amadio Jr","year":"1983","unstructured":"Amadio PJr, Cummings DM: Evaluation of acetaminophen in the management of osteoarthritis of the knee. Curr Ther Res 1983, 34:59\u201366.","journal-title":"Curr Ther Res"},{"issue":"2","key":"20_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199107113250203","volume":"325","author":"JD Bradley","year":"1991","unstructured":"Bradley JD, Brandt KD, Katz BP, et al.: Comparison of an antiinflammatory dose of Ibuprofen, an analgesic dose of Ibuprofen and acetaminophen in the treatment of patients with OA of the knee. N Engl J Med 1991, 325(2):87\u201391.","journal-title":"N Engl J Med"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.1780360904","volume":"9","author":"HJ Williams","year":"1993","unstructured":"Williams HJ, Ward JR, Egger MJ, et al.: Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993, 9:1196\u2013206.","journal-title":"Arthritis Rheum"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"AR Temple","year":"2000","unstructured":"Temple AR, Reel LJ, Fox TM, Lynch JM: Long-term use of acetaminophen in osteoarthritis pain [abstract]. Ann Rheum Dis 2000, 59:135.","journal-title":"Ann Rheum Dis"},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.317.7157.526","volume":"317","author":"M Eccles","year":"1998","unstructured":"Eccles M, Freemantle N, Mason J, for the North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group: North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. BMJ 1998, 317:526\u2013530.","journal-title":"BMJ"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.309.6961.1041","volume":"309","author":"L March","year":"1994","unstructured":"March L, Irving L, Schwarz J, et al.: N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994, 309:1041\u20131046.","journal-title":"BMJ"},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.310.6980.667","volume":"310","author":"S Senn","year":"1995","unstructured":"Senn S, Bateshi R, Ezzet N: N of 1 trials in osteoarthritis: N of 1 trials in interpretation needed [letter]. BMJ 1995, 310:667.","journal-title":"BMJ"},{"key":"20_CR31","first-page":"S403","volume":"42","author":"RD Altman","year":"1999","unstructured":"Altman RD for the IAP Study Group: Ibuprofen, acetaminophen and placebo in osteoarthritis of the knee: a six-day double-blind study [abstract]. Arthritis Rheum 1999, 42:S403.","journal-title":"Arthritis Rheum"},{"key":"20_CR32","first-page":"S404","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Callahan LF, Wolfe F, et al.: Arthrotec compared to acetaminophen: a clinical trial in patients with osteoarthritis of the hip or knee. Arthritis Rheum 1999, 42:S404.","journal-title":"Arthritis Rheum"},{"key":"20_CR33","first-page":"133","volume":"59","author":"GP Geba","year":"2000","unstructured":"Geba GP, Weaver AL, Schnitzer TJ, et al.: A clinical trial comparing rofecoxib to celecoxib and acetaminophen in the treatment of osteoarthritis: early efficacy results [abstract]. Ann Rheum Dis 2000, 59:133.","journal-title":"Ann Rheum Dis"},{"key":"20_CR34","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","volume":"273","author":"DC Whitcomb","year":"1994","unstructured":"Whitcomb DC, Block GD: Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994, 273:1845\u20131850.","journal-title":"JAMA"},{"key":"20_CR35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","volume":"337","author":"FV Schiodt","year":"1997","unstructured":"Schiodt FV, Rochling FA, Casey DL, Lee WM: Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997, 337:1112\u20131117.","journal-title":"N Engl J Med"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","volume":"331","author":"TV Perneger","year":"1994","unstructured":"Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994, 331:1675\u20131679.","journal-title":"N Engl J Med"},{"key":"20_CR37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0272-6386(96)90046-3","volume":"27","author":"WL Henrich","year":"1996","unstructured":"Henrich WL, Agodaoa LE, Barret B, et al.: Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis 1996, 27:162\u2013165.","journal-title":"Am J Kidney Dis"},{"key":"20_CR38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.279.9.657","volume":"279","author":"M Hylek","year":"1998","unstructured":"Hylek M, Heiman H, Skates SJ, et al.: Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998, 279:657\u2013662.","journal-title":"JAMA"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1529-0131(199606)9:3<170::AID-ANR1790090304>3.0.CO;2-K","volume":"9","author":"MC Hochberg","year":"1996","unstructured":"Hochberg MC, Perlmutter D, Hudson J, Altinar K: Preferences in the management of osteoarthritis of the hip and knee: results of a survey of community-based rheumatologists in the US. Arthritis Care Res 1996, 9:170\u2013176.","journal-title":"Arthritis Care Res"},{"key":"20_CR40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/art.1790100503","volume":"10","author":"SA Mazzuca","year":"1997","unstructured":"Mazzuca SA, Brandt KD, Katz BP, et al.: Comparison of general internists, family physicians, and rheumatologists managing patients with symptoms of osteoarthritis of the knee. Arthritis Care Res 1997, 10:289\u2013299.","journal-title":"Arthritis Care Res"},{"key":"20_CR41","first-page":"1020","volume":"27","author":"T Pincus","year":"2000","unstructured":"Pincus T, Swearingen C, Cummins P, Callahan LF: Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000, 27:1020\u20131027.","journal-title":"J Rheumatol"},{"key":"20_CR42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2","volume":"43","author":"F Wolfe","year":"2000","unstructured":"Wolfe F, Zhao S, Lane N: Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000, 43:378\u2013385.","journal-title":"Arthritis Rheum"},{"key":"20_CR43","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","volume":"43","author":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","year":"2000","unstructured":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthiritis of the hip and knee: 2000 update. Arthritis Rheum 2000, 43:1905\u20131915.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-000-0020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-000-0020-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T21:29:44Z","timestamp":1737062984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-000-0020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11926-000-0020-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}